GYRE

GYRE THERAPEUTICS INC

GYRE·403783103·US·Common Stock·Healthcare - Biotechnology-Activist

GYRE (GYRE THERAPEUTICS INC) is held by 40 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($6.6M), VANGUARD CAPITAL MANAGEMENT LLC ($5.8M), GEODE CAPITAL MANAGEMENT, LLC ($3.5M). Net institutional sentiment: Bullish.

40
Holders
(3 Elite)
$24.8M
Total Value
76% (42)
Consensus
32 buying - 10 selling
13F: Insider & Congress: Updated regularly
GYRE

Smart Money Verdict

View all
Loading verdict
Held by 40 funds
3 elite

Who's Trading

Source dates: Price Aug 31, 2026 · Insiders Jun 11, 2026 · Activists May 7, 2026 · Congress none

InsiderYWYe WeiguoSell $40KJun 10, 2026
InsiderYWYe WeiguoExercise 6K shJun 10, 2026
InsiderYWYe WeiguoExercise 15K shJun 9, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
993,943(+31.0%)$6.6M0.0%-30.13%
35
Decreased
876,927(-10.9%)$5.8M0.0%-16.58%
0
Increased
532,950(+23.5%)$3.5M0.0%-50.12%
32
Increased
245,402(+13.4%)$1.6M0.0%-40.91%
20
Increased
184,286(+11.5%)$1.2M0.0%-35.07%
28
Increased
169,537(+26.7%)$1.1M0.0%-42.00%
31
Increased
151,073(+9.7%)$995,5710.0%-15.34%
27
Increased
123,953(+77.5%)$816,8500.0%-10.07%
26
Increased
86,235(+17.9%)$568,2890.0%-11.94%
19
Increased
62,750(+45.4%)$413,5230.0%-19.18%
32
Increased
41,691(+382.5%)$274,7430.0%-2.53%
26
Increased
24,590(+12.6%)$171,3920.0%-10.13%
25
Increased
25,800(+22.3%)$170,0220.0%-9.64%
27
Unchanged
25,268$166,5160.0%-12.37%
0
New
24,505$161,4880.0%0.00%
34
Decreased
18,763(-11.0%)$123,6490.0%-23.34%
0
New
18,488$121,8360.0%0.00%
34
Increased
17,939(+69.0%)$118,2180.0%-6.93%
22
Increased
16,865(+28.6%)$111,1310.0%-30.24%
27
Increased
16,297(+279.9%)$107,3970.0%-6.88%
24

Showing 1-20 of 46

1 / 3
GYREGYREGYRE THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used